Pharvaris PHVS
NASDAQ PHVS
$36.26 +0.60 (+1.68%)
As of: Sep 4, 2026 · 2:10 PM EDT

Pharvaris (PHVS) Gross Profit (QoQ) (2025 - 2026)

Analysis

Pharvaris (PHVS) Gross Profit (QoQ) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.72 Bn 77.72 Bn 3.93 Bn
3 Argenx Se 63.56 Bn 58.37 Bn 1.37 Bn
4 Moderna 58.22 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.18 Bn 44.18 Bn -
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.31 Bn 32.00 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.43 Bn 26.27 Bn 358.27 Mn
10 Pharvaris 2.15 Bn 1.78 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.17%
Jun 30, 2025 167.27%